APDN

Applied DNA Sciences Inc - Pursuing Divestiture of Certaint Platform, Implements Changes to Corporate Leadership

时间:2024-12-18 05:08:14 市场: 美股 综合

关联: APDN

Applied DNA Sciences Inc - Net Loss for Q4 of Fiscal 2024 Was $0.32 per Share

时间:2024-12-18 05:08:14 市场: 综合 美股

关联: APDN

Applied DNA Sciences - Pricing of $6.5 Mln Registered Direct Offering and Concurrent Private Placement

时间:2024-10-30 19:18:06 市场: 美股 综合

关联: APDN

Amh Equity Llc Reports 9.71% Passive Stake in Applied DNA Sciences Inc as of Oct 1 - SEC Filing

时间:2024-10-03 04:42:37 市场: 美股 综合

关联: APDN

Applied DNA Regains Compliance With Nasdaq Minimum Bid Price Requirement

时间:2024-09-18 21:05:58 市场: 美股 综合

关联: APDN

Sector Update: Health Care Stocks Softer in Afternoon Trading Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index shedding 0.2% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.6%.The iShares Biotechnology ETF (IBB) rose 0.2%.In corporate news, Applied DNA Sciences (APDN) shares surged 27% after the company said it was expanding its clinical testing services to include the detection of Mpox Clade I and Clade II.Renovaro (RENB) shares dropped 4.2% after it said Wednesday it's offering up to a 20% stake in its cancer-diagnostics unit RenovaroCube to new or existing investors.BriaCell Therapeutics (BCTX) shares jumped 12% after it reported positive overall survival data in a phase 2 late-stage metastatic breast cancer study evaluating Bria-IMT plus an immune check point inhibitor. Separately, BriaCell said Wednesday it has priced an offering of about 12.3 million shares at $0.69 per share for gross proceeds of about $8.5 million.

时间:2024-09-12 02:04:16 市场: 综合 美股

关联: RENB NYSE DNA APDN FDN

Applied DNA Sciences Inc - Launches Mpox Clade I and Clade Ii Testing Service

时间:2024-09-11 21:03:53 市场: 美股 综合

关联: APDN